基金supported by the Natural Science Foundations of Anhui Province Education Department(No.2024AH051118,2024AH051082,2023AH040073)Anhui Provincial Quality Engineering Project(No.2022zygzts061,2023cxcysj146,2023sdxx049,2022xqhz040)+1 种基金the Excellent Teachers Cultivation Project in 2024 of Anhui Province Education Department(No.YQYB2024037)Open Fund Projects of the Province Key Laboratory of the Biodiversity Study and Ecology Conservation in Southwest Anhui(No.Wsy202202).
文摘三阴性乳腺癌(triple-negative breast cancer,TNBC)以高侵袭转移、预后不良、死亡率高为特征,是恶性最强的乳腺癌,目前仍缺乏有效的治疗靶点。磷脂酰肌醇3-激酶(phosphatidylinositol 3-kinase,PI3K)/蛋白激酶B(protein kinase B,AKT)/哺乳动物雷帕霉素靶蛋白(mammalian target of rapamycin,mTOR)通路在TNBC中普遍异常激活,导致TNBC患者化疗药物耐药性增加、临床预后不良。非编码RNA(non-coding RNA,ncRNA)包括微小RNA(microRNA,miRNA)、长链非编码RNA(long noncoding RNA,lncRNA)和环状RNA(circular RNA,circRNA)等,参与多种生物学过程,可作为致癌基因或抑癌基因调控PI3K/AKT/mTOR信号通路,促进或抑制TNBC的发生和发展。本文综述了TNBC中一些重要的miRNA,lncRNA,circRNA及其调控PI3K/AKT/mTOR信号通路的靶点和分子机制,希望为TNBC的研究开辟新的途径,最终促进TNBC精确有效治疗的发展。